These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 11096483)

  • 1. Torsades de Pointes.
    Viskin S
    Curr Treat Options Cardiovasc Med; 1999 Aug; 1(2):187-195. PubMed ID: 11096483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of torsade de pointes in the congenital long QT syndrome: use of a pause prevention pacing algorithm.
    Viskin S; Fish R; Roth A; Copperman Y
    Heart; 1998 Apr; 79(4):417-9. PubMed ID: 9616356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rate smoothing with cardiac pacing for preventing torsade de pointes.
    Viskin S; Glikson M; Fish R; Glick A; Copperman Y; Saxon LA
    Am J Cardiol; 2000 Nov; 86(9A):111K-115K. PubMed ID: 11084109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mode of onset of torsade de pointes in congenital long QT syndrome.
    Viskin S; Alla SR; Barron HV; Heller K; Saxon L; Kitzis I; Hare GF; Wong MJ; Lesh MD; Scheinman MM
    J Am Coll Cardiol; 1996 Nov; 28(5):1262-8. PubMed ID: 8890825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Giant T-U waves precede torsades de pointes in long QT syndrome: a systematic electrocardiographic analysis in patients with acquired and congenital QT prolongation.
    Kirchhof P; Franz MR; Bardai A; Wilde AM
    J Am Coll Cardiol; 2009 Jul; 54(2):143-9. PubMed ID: 19573731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study.
    Salem JE; Bretagne M; Lebrun-Vignes B; Waintraub X; Gandjbakhch E; Hidden-Lucet F; Gougis P; Bachelot A; Funck-Brentano C;
    Arch Cardiovasc Dis; 2019 Nov; 112(11):699-712. PubMed ID: 31477476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive factors of ventricular fibrillation triggered by pause-dependent torsades de pointes associated with acquired long QT interval: role of QT dispersion and left ventricular function.
    Da Costa A; Chalvidan T; Belounas A; Messier M; Viallet M; Mansour H; Lamaison D; Djiane P; Isaaz K
    J Cardiovasc Electrophysiol; 2000 Sep; 11(9):990-7. PubMed ID: 11021469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental models of torsades de pointes.
    Weissenburger J; Davy JM; Chézalviel F
    Fundam Clin Pharmacol; 1993; 7(1):29-38. PubMed ID: 8458600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Torsades de pointes associated with acquired long QT syndrome: observation of 7 cases.
    Takahashi N; Ito M; Inoue T; Koumatsu K; Takeshita Y; Tsumabuki S; Tamura M; Inoue K; Maeda T; Saikawa T
    J Cardiol; 1993; 23(1):99-106. PubMed ID: 8164140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Terminology of torsades de pointes.
    Tzivoni D; Keren A; Banai S; Stern S
    Cardiovasc Drugs Ther; 1991 Apr; 5(2):505-7. PubMed ID: 1854659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Torsades de pointes].
    Guize L; Iliou MC; Bayet G; Lavergne T; Le Heuzey JY
    Arch Mal Coeur Vaiss; 1993 May; 86(5 Suppl):769-76. PubMed ID: 8267505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arrhythmias in the congenital long QT syndrome: how often is torsade de pointes pause dependent?
    Viskin S; Fish R; Zeltser D; Belhassen B; Heller K; Brosh D; Laniado S; Barron HV
    Heart; 2000 Jun; 83(6):661-6. PubMed ID: 10814624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical toxicologists' practice patterns regarding drug-induced QT prolongation in overdose patients: a survey in the United States of America, Europe, and Asia Pacific region.
    Othong R; Devlin JJ; Kazzi ZN
    Clin Toxicol (Phila); 2015 May; 53(4):204-9. PubMed ID: 25706450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful uses of magnesium sulfate for torsades de pointes in children with long QT syndrome.
    Hoshino K; Ogawa K; Hishitani T; Isobe T; Etoh Y
    Pediatr Int; 2006 Apr; 48(2):112-7. PubMed ID: 16635167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relations of QTc prolongation on the electrocardiogram to torsades de pointes: definitions and mechanisms.
    Morganroth J
    Am J Cardiol; 1993 Aug; 72(6):10B-13B. PubMed ID: 8256748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug therapy for torsade de pointes.
    Banai S; Tzivoni D
    J Cardiovasc Electrophysiol; 1993 Apr; 4(2):206-10. PubMed ID: 8269292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mexiletine Prevents Recurrent Torsades de Pointes in Acquired Long QT Syndrome Refractory to Conventional Measures.
    Badri M; Patel A; Patel C; Liu G; Goldstein M; Robinson VM; Xue X; Yang L; Kowey PR; Yan GX
    JACC Clin Electrophysiol; 2015 Aug; 1(4):315-322. PubMed ID: 29759319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium pentobarbital reduces transmural dispersion of repolarization and prevents torsades de Pointes in models of acquired and congenital long QT syndrome.
    Shimizu W; McMahon B; Antzelevitch C
    J Cardiovasc Electrophysiol; 1999 Feb; 10(2):154-64. PubMed ID: 10090218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing torsades de pointes by careful cardiac monitoring in hospital settings.
    Sommargren CE; Drew BJ
    AACN Adv Crit Care; 2007; 18(3):285-93. PubMed ID: 18019519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Torsades de pointes initiated by slow ventricular stimulation].
    Fontaine G; Frank R; Lascault G; Tonet JL; Fillette F; Grosgogeat Y
    Arch Mal Coeur Vaiss; 1983 Aug; 76(8):918-24. PubMed ID: 6414425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.